Ra Capital Management as of March 31, 2016
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 42 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 12.6 | $98M | 7.1M | 13.88 | |
| Achillion Pharmaceuticals | 11.9 | $93M | 12M | 7.72 | |
| Axovant Sciences | 7.3 | $57M | 5.0M | 11.48 | |
| Aclaris Therapeutics (ACRS) | 6.4 | $50M | 2.6M | 18.95 | |
| Nektar Therapeutics (NKTR) | 5.6 | $44M | 3.2M | 13.75 | |
| Ascendis Pharma A S (ASND) | 5.1 | $40M | 2.2M | 18.55 | |
| Tg Therapeutics (TGTX) | 4.9 | $39M | 4.5M | 8.52 | |
| Avexis | 4.7 | $37M | 1.4M | 27.24 | |
| Coherus Biosciences (CHRS) | 3.5 | $27M | 1.3M | 21.23 | |
| Zogenix | 2.9 | $23M | 2.5M | 9.24 | |
| Arena Pharmaceuticals | 2.4 | $18M | 9.4M | 1.97 | |
| Ardelyx (ARDX) | 2.3 | $18M | 2.3M | 7.77 | |
| Aimmune Therapeutics | 2.2 | $18M | 1.3M | 13.56 | |
| Celator Pharmaceuticals | 2.0 | $16M | 1.4M | 11.03 | |
| Aquinox Pharmaceuticals | 1.9 | $15M | 1.7M | 8.82 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.9 | $15M | 1.2M | 12.70 | |
| Sangamo Biosciences (SGMO) | 1.7 | $13M | 2.2M | 6.05 | |
| Acorda Therapeutics | 1.7 | $13M | 498k | 26.45 | |
| Dicerna Pharmaceuticals | 1.7 | $13M | 2.4M | 5.36 | |
| Proteon Therapeutics | 1.6 | $13M | 1.6M | 7.74 | |
| Strongbridge Bioph shs usd | 1.6 | $12M | 2.7M | 4.56 | |
| Dimension Therapeutics | 1.6 | $12M | 1.5M | 7.83 | |
| Alcobra | 1.5 | $12M | 3.0M | 3.79 | |
| Vitae Pharmaceuticals | 1.3 | $10M | 1.6M | 6.63 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.1 | $8.8M | 487k | 18.15 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $8.5M | 3.0M | 2.83 | |
| Natera (NTRA) | 0.9 | $7.5M | 784k | 9.52 | |
| Regulus Therapeutics | 0.9 | $7.2M | 1.0M | 6.93 | |
| Agile Therapeutics | 0.8 | $6.6M | 1.1M | 6.21 | |
| Beigene (BGNE) | 0.6 | $5.0M | 170k | 29.31 | |
| Tenax Therapeutics | 0.6 | $4.9M | 2.4M | 2.05 | |
| Eiger Biopharmaceuticals | 0.6 | $4.9M | 292k | 16.77 | |
| Zynerba Pharmaceuticals | 0.6 | $4.8M | 507k | 9.45 | |
| Pronai Therapeutics | 0.5 | $4.1M | 605k | 6.74 | |
| Applied Genetic Technol Corp C | 0.4 | $3.3M | 236k | 13.98 | |
| Arca Biopharma | 0.3 | $2.7M | 778k | 3.47 | |
| Nivalis Therapeutics | 0.3 | $2.6M | 613k | 4.17 | |
| Akari Therapeutics | 0.3 | $2.6M | 258k | 10.08 | |
| Neuroderm Ltd F | 0.3 | $2.0M | 145k | 14.12 | |
| Blueprint Medicines (BPMC) | 0.1 | $1.0M | 56k | 18.05 | |
| Derma Sciences | 0.0 | $252k | 81k | 3.10 | |
| Ampliphi Biosciences | 0.0 | $211k | 54k | 3.94 |
